These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30987266)
1. Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma. Mishra H; Mishra PK; Iqbal Z; Jaggi M; Madaan A; Bhuyan K; Gupta N; Gupta N; Vats K; Verma R; Talegaonkar S Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30987266 [TBL] [Abstract][Full Text] [Related]
2. Functionalized nanoliposomes loaded with anti survivin and anti angiogenic agents to enhance the activity of chemotherapy against melanoma by 4-pronged action. Mishra H; Mishra PK; Ekielski A; Iqbal Z; Jaggi M; Talegaonkar S Med Hypotheses; 2018 Jul; 116():141-146. PubMed ID: 29857900 [TBL] [Abstract][Full Text] [Related]
3. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma. Yang J; Zhao R; Feng Q; Zhuo X; Wang R Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135 [TBL] [Abstract][Full Text] [Related]
4. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672 [TBL] [Abstract][Full Text] [Related]
5. Bixin, an apocarotenoid isolated from Bixa orellana L., sensitizes human melanoma cells to dacarbazine-induced apoptosis through ROS-mediated cytotoxicity. de Oliveira Júnior RG; Bonnet A; Braconnier E; Groult H; Prunier G; Beaugeard L; Grougnet R; da Silva Almeida JRG; Ferraz CAA; Picot L Food Chem Toxicol; 2019 Mar; 125():549-561. PubMed ID: 30738990 [TBL] [Abstract][Full Text] [Related]
6. Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration. Sabir F; Katona G; Pallagi E; Dobó DG; Akel H; Berkesi D; Kónya Z; Csóka I Molecules; 2021 Mar; 26(5):. PubMed ID: 33800788 [TBL] [Abstract][Full Text] [Related]
7. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation. Al-Sharif I; Remmal A; Aboussekhra A BMC Cancer; 2013 Dec; 13():600. PubMed ID: 24330704 [TBL] [Abstract][Full Text] [Related]
8. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. Mahira S; Kommineni N; Husain GM; Khan W Biomed Pharmacother; 2019 Feb; 110():803-817. PubMed ID: 30554119 [TBL] [Abstract][Full Text] [Related]
9. The Cytotoxicity of Dacarbazine Potentiated by Sea Cucumber Saponin in Resistant B16F10 Melanoma Cells through Apoptosis Induction. Baharara J; Amini E; Nikdel N; Salek-Abdollahi F Avicenna J Med Biotechnol; 2016; 8(3):112-9. PubMed ID: 27563423 [TBL] [Abstract][Full Text] [Related]
10. Dacarbazine-Loaded Hollow Mesoporous Silica Nanoparticles Grafted with Folic Acid for Enhancing Antimetastatic Melanoma Response. Liu Q; Xu N; Liu L; Li J; Zhang Y; Shen C; Shezad K; Zhang L; Zhu J; Tao J ACS Appl Mater Interfaces; 2017 Jul; 9(26):21673-21687. PubMed ID: 28590113 [TBL] [Abstract][Full Text] [Related]
12. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine. Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes. Liu D; Zhang Q; Wang J; Guan S; Cai D; Liu J Carbohydr Polym; 2021 Apr; 257():117572. PubMed ID: 33541631 [TBL] [Abstract][Full Text] [Related]
14. Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma. Li C; Han X Nanoscale Res Lett; 2020 May; 15(1):113. PubMed ID: 32430641 [TBL] [Abstract][Full Text] [Related]
15. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation. Shaji J; Menon I Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699 [TBL] [Abstract][Full Text] [Related]
16. Parthenolide enhances dacarbazine activity against melanoma cells. Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801 [TBL] [Abstract][Full Text] [Related]
17. Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma. Ataabadi FV; Oveissi F; Etebari M; Taheri A Carbohydr Polym; 2023 Sep; 316():121041. PubMed ID: 37321735 [TBL] [Abstract][Full Text] [Related]
18. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity. Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975 [TBL] [Abstract][Full Text] [Related]
19. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535 [TBL] [Abstract][Full Text] [Related]